Provides scientific and strategic leadership for real-world evidence supporting an mRNA vaccine portfolio, with a primary focus on influenza. Shapes evidence generation across late-stage development, launch and post-marketing, leading US post-marketing vaccine effectiveness studies and complex external collaborations with academic and healthcare data partners.
Provides scientific and strategic leadership for real-world evidence supporting an mRNA vaccine portfolio, with a primary focus on influenza. Shapes evidence generation across late-stage development, launch and post-marketing phases, leading US post-marketing vaccine effectiveness studies and complex external collaborations with academic and healthcare data partners.
Leads epidemiology programs for one or more assets or disease areas, setting strategy and timelines with clinical development, safety, regulatory, outcomes and commercial partners. Designs and delivers observational and database studies using real-world data, registries and linked sources, and provides scientific advice on study design, analysis plans and interpretation. Manages external vendors, budgets and timelines, and prepares regulatory documents, technical reports and publications.
Leads epidemiology programs for one or more assets or disease areas, setting strategy and timelines with clinical development, safety, regulatory, outcomes and commercial partners. Designs, oversees and delivers observational and database studies using real-world data, registries and linked sources, and provides scientific advice on study design, data needs and analysis plans. Also manages external vendors, budgets and timelines, and prepares regulatory documents, technical reports and publications.
Manages statistical planning and delivery across oncology clinical programs, designing trials and analyses that shape development decisions and regulatory strategy. Works with clinical, regulatory, safety and clinical pharmacology teams, using simulation and advanced methods in R or Python, and mentors statisticians. Based in London or Stevenage, with a planned relocation to Cambridge by early 2029.
Hands-on role designing, building and maintaining modular end-to-end data-flows across GSK's R&D division, integrating diverse sources into reusable, machine-readable assets with compliance built into the pipeline. Combines technical delivery and coding with coaching and peer review to embed industry best practice, working in a complex matrix environment with varied stakeholders.
Designs, builds and maintains modular end-to-end data-flows across GSK's R&D division, integrating diverse sources such as protocol development, DSUR and clinical trial data into a unified machine-readable format. Combines hands-on coding and orchestration with compliance-by-design, documentation and coaching or peer review to embed industry best practice.
Designs and governs modular, end-to-end data-flows for GSK's R&D division, turning scattered systems into reusable, compliance-by-design assets in a machine-readable format. Involves translating business needs into technical data requirements, policy-as-code, metadata ecosystems and agentic solutions, with coaching and peer review across matrix teams.
Leads cross-functional teams designing and operating Lab-in-an-Automated-Loop systems that integrate computational intelligence with physical lab experimentation in adaptive learning cycles. Translates scientific requirements into system designs and platform capabilities, applying AI, agents and cloud-based workflow automation to accelerate medicine discovery. Hybrid role requiring on-site presence 2-3 days per week.
Provides medical and scientific expertise in safety evaluation and risk management for GSK products across clinical development and post-marketing settings. Responsible for signal detection, benefit-risk assessment, authoring risk management plans and aggregate safety reports, and supporting inspection readiness. Works within a cross-functional matrix team, escalating safety issues to governance bodies and supporting risk-reduction strategies in protocols and labelling.
Provides scientific and strategic leadership for real-world evidence supporting GSK's mRNA vaccine portfolio, with a primary focus on influenza. Leads post-marketing vaccine effectiveness studies in the US, translating evidence needs into rigorous study designs and building collaborations with academic investigators, healthcare systems and data partners. Requires deep expertise in US vaccine effectiveness research, influenza epidemiology, real-world data and causal methods.
Acts as the operational hub for oncology assets, owning the integrated project plan, budget and risk inputs while driving critical-path acceleration and governance decisions. Partners with project leads to navigate uncertainty, facilitate high-performing teams and embed consistent project management practices across the pipeline.
Acts as the operational 'COO' of a drug or vaccine asset, owning the single integrated project plan and partnering with project leads to steer strategy through complexity. Drives critical-path acceleration, risk management, governance preparation and cross-functional handoffs, with budget and resource forecasting using tools such as Planisware or MS Project.
Founding leadership role accountable for defining the vision, strategy, operating model and governance of innovation across the Chief Medical Office, owning the innovation portfolio and its measurable business impact. Involves embedding AI-, data- and digital-enabled ways of working, chairing governance forums, and building a new team from three direct reports toward 10-20 FTEs.
Founding leadership role accountable for defining the vision, strategy, operating model and governance of innovation across the Chief Medical Office, owning the innovation portfolio and its measurable business impact. Involves embedding AI-, data- and digital-enabled ways of working, chairing governance forums, and building a team from three direct reports toward 10-20 FTEs.
